Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 47Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Allergan Inc.

02 3Ferring Inc.

03 1Gowling WLG (Canada) LLP

04 7Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : ASACOL 800

Patent Number : 2444814

Filing Date : 2001-10-24

Strength per Unit : 800mg

Dosage Form : Enteric Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-10-24

Date Granted : 2009-06-09

Abbvie CB

02

arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : ASACOL 800

Patent Number : 2359812

Filing Date : 2001-10-24

Strength per Unit : 800mg

Dosage Form : Enteric Coated Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-10-24

Date Granted : 2004-02-10

Abbvie CB

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : PENTASA

Patent Number : 2111697

Filing Date : 1992-06-16

Strength per Unit : 1 g

Dosage Form : Suppositories

Human Or VET : Human

Route of Administration : Rectal

Patent Expiration Date : 2012-06-16

Date Granted : 2002-08-20

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : PENTASA

Patent Number : 2462905

Filing Date : 2001-10-15

Strength per Unit : 500 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-10-15

Date Granted : 2011-04-12

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : PENTASA

Patent Number : 2462905

Filing Date : 2004-04-05

Strength per Unit : 1g

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-10-15

Date Granted : 2011-04-12

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name : MEZAVANT

Patent Number : 2377299

Filing Date : 2000-06-08

Strength per Unit : 1.2g

Dosage Form : Tablet (Delayed and Extended Release)

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2020-06-08

Date Granted : 2009-05-12

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name :

Patent Number : 1172570

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2002-07-29

Date Granted :

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name :

Patent Number : 1222459

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-06-02

Date Granted :

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name :

Patent Number : 1222459

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-06-02

Date Granted :

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed

Country
arrow
Medlab Asia & Asia Health
Not Confirmed

Mesalazine

Brand Name :

Patent Number : 1222459

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2004-06-02

Date Granted :

blank